A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy. A gene linked to immune system function may help predict which ...

The rapid expansion of clinical genetic testing has markedly improved the detection of genetic variants. However, most variants lack the evidence needed to classify them as pathogenic or benign, ...

Cedars-Sinai investigators have developed a novel artificial intelligence (AI) model, named DYNA, that accurately distinguishes harmful gene variations from harmless ones, potentially enhancing ...

Over three percent of people carry a dominant pathogenic variant, yet only a fraction of carriers develop disease. Disease phenotypes from carriers of variants in the same gene range from mild to ...

Genes get passed down from parents, determining traits such as eye color and height as well as risk for certain diseases. And while cancer-linked genes such as BRCA1 and TP53 are relatively familiar, ...

Whether we are predisposed to particular diseases may depend to a large extent on variations in our genomes, but the influence on the presentation of certain pathological traits of genetic variants ...

Researchers have mapped the exact variants in a gene that dramatically increase a person's risk of developing several types of cancer. This could lead to improved early detection and targeted ...

Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome. However, particularly in the case of genetic variants that only rarely occur in the ...